The biomaterials market will touch USD 349.1 billion by 2030, powering at a rate of 13.4% in the years to come.
The growth of the industry is encouraged by tech progressions, the increasing prevalence of musculoskeletal and skeletal conditions, and increasing support of the governments, such as funds and grants for increasing the production of advanced biomaterials.
The elderly people require extensive care as they are prone to illnesses, as a result of low immunity and high recovery time. As a result of the changes in tendons and ligaments with age, the flexibility of joints decreases, and their motion turn out to be more restricted.
North America biomaterials market had the largest revenue, about USD 50 billion in the past. This is because of the increasing healthcare spending, increasing support of the government, and growing consciousness regarding implantable medical devices.
Germany has a considerable share in Europe, because of the growing requirement for minimally invasive surgeries, high level of patient consciousness, and the existence of cutting-edge healthcare infra for joint replacement surgery.
It is because of the increasing tech-advancements in the field of medical science, the need for biomaterials is on the rise all over the world.